The Aesthetic Guide is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

FDA expected to approve OTC cellulite-reduction devices

Article-FDA expected to approve OTC cellulite-reduction devices

Waltham, Mass. — The number of people receiving laser and energy device-assisted cellulite reduction is likely to increase dramatically over next five years, according to an industry study reported by PRNewswire.

According to Millennium Research Group (MRG), a Waltham-based medical-device and pharmaceutical-industry analyst and consulting firm, 330,000 people in the United States received such procedures in 2006, and by 2011 that number will more than double.

MRG’s “U.S. Markets for Aesthetics Lasers and Energy Devices 2007,” says that while most aesthetic laser procedures require some level of physician supervision, a number of noninvasive cellulite-reduction devices will gain over-the-counter approval by the FDA — and will be adopted for use in spas because they generate bigger profit margins than most spa-based procedures.

PRNewswire quotes MRG Senior Analyst Jaya Classen as saying, “Although cellulite occurs in individuals of varying weights, cellulite severity is correlated with increased weight. In the U.S., the average weight is increasing annually, particularly in younger generations, thereby expanding the population pool for cellulite-reduction treatment. The expanding patient pool, combined with increasing awareness and acceptance of medical cellulite-reduction procedures, will drive growth in this market through 2011 and beyond.”

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.